Short term effect of non-steroidal anti-inflammatory drugs on clinical and magnetic resonance imaging of the sacroiliac joints progression in axial spondyloarthritis patients

Rudwaleit, 2005, The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?, Arthritis Rheum, 52, 1000, 10.1002/art.20990 Sieper, 2013, Review: nonradiographic axial spondyloarthritis: new definition of an old disease?, Arthritis Rheum, 65, 543, 10.1002/art.37803 Abdelsalam, 2017, Demographic, clinical and radiological characteristics of seronegative spondyloarthritis Egyptian patients: A rheumatology clinic experience in Mansoura, Egypt Rheumatol, 39, 109, 10.1016/j.ejr.2016.08.002 Zochling, 2006, ASAS/EULAR recommendations for the management of ankylosing spondylitis, Ann Rheum Dis, 65, 442, 10.1136/ard.2005.041137 Smolen, 2016, Treat-to-target as an approach in inflammatory arthritis, Curr Opin Rheumatol, 28, 297, 10.1097/BOR.0000000000000284 van der Heijde, 2017, 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis, Ann Rheum Dis, 76, 978, 10.1136/annrheumdis-2016-210770 Poddubnyy, 2012, Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort, Ann Rheum Dis, 71, 1616, 10.1136/annrheumdis-2011-201252 Kroon, 2012, Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis, Ann Rheum Dis, 71, 1623, 10.1136/annrheumdis-2012-201370 Haroon, 2012, NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms?, Ann Rheum Dis, 71, 1593, 10.1136/annrheumdis-2012-201844 Sieper, 2017, Axial spondyloarthritis, Lancet, 390, 73, 10.1016/S0140-6736(16)31591-4 Rudwaleit, 2009, The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection, Ann Rheum Dis, 68, 777, 10.1136/ard.2009.108233 Garrett, 1994, A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index, J Rheumatol, 21, 2286 Thomas, 2017, Genetic diagnostic profiling in axial spondyloarthritis: a real world study, Clin Exp Rheumatol, 35, 229 Machado, 2018, Assessment of SpondyloArthritis international Society (ASAS) Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states, Ann Rheum Dis, 77, 1539, 10.1136/annrheumdis-2018-213184 Calin, 1994, A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index, J Rheumatol., 21, 2281 Zochling, 2011, Arthritis Care Res (Hoboken), 63, S47, 10.1002/acr.20575 Jenkinson, 1994, Defining spinal mobility in Ankylosing Spondylitis (AS). The Bath AS Metrology Index, J Rheumatol, 21, 1694 Landewé, 2015, Clinical tools to assess and monitor Spondyloarthritis, Curr Rheumatol Rep, 17, 47, 10.1007/s11926-015-0522-3 Sieper, 2011, The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis, Ann Rheum Dis, 68, ii1 Dougados, 2011, ASAS recommendations for collecting, analyzing and reporting NSAID intake in clinical trials/ epidemiological studies in axial spondyloarthritis, Ann Rheum Dis, 70, 249, 10.1136/ard.2010.133488 Hermann, 2012, Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group, Ann Rheum Dis, 71, 1278, 10.1136/ard.2011.150680 Hededal, 2018, Development and Validation of MRI Sacroiliac Joint Scoring Methods for the Semiaxial Scan Plane Corresponding to the Berlin and SPARCC MRI Scoring Methods, and of a New Global MRI Sacroiliac Joint Method, J Rheumatol, 45, 70, 10.3899/jrheum.161583 Gheita, 2015, Bone scintigraphy in axial seronegative spondyloarthritis patients: role in detection of subclinical peripheral arthritis and disease activity, Int J Rheum Dis, 18, 553, 10.1111/1756-185X.12527 Mahmoud, 2016, Limit of the available spine radiologic scoring methods in ankylosing spondylitis when the facet joint is the only structure involved, Egypt Rheumatol, 38, 203, 10.1016/j.ejr.2015.08.004 Rumiantceva, 2018, SAT0278 NSAID reduces radiographic progression in sacloiliac joints in early axial spondyloarthritis, Ann Rheum Dis, 77, 1003 Poddubnyy, 2011, Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis, Ann Rheum Dis, 70, 1369, 10.1136/ard.2010.145995 Blachier, 2013, Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort, Rheumatology, 52, 1686, 10.1093/rheumatology/ket207 Brown, 2018, Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study, Ann Rheum Dis, 77, 1091, 10.1136/annrheumdis-2017-211313 Sebastian, 2017, Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy, Reumatologia, 55, 157, 10.5114/reum.2017.69775 Rekik, 2018, Effectiveness, safety and drug survival of tumor necrosis factor-α inhibitors in the treatment of spondyloarthritis: a real-life study in Tunisia, Egypt. Rheumatol., 40, 255, 10.1016/j.ejr.2017.10.007 Varkas, 2016, Brief report: six-week treatment of axial spondyloarthritis patients with an optimal dose of nonsteroidal antiinflammatory drugs: early response to treatment in signal intensity on magnetic resonance imaging of the sacroiliac joints, Arthritis Rheumatol, 68, 672, 10.1002/art.39474 Braun, 2003, Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial, Arthritis Rheum, 48, 2224, 10.1002/art.11104 Baraliakos, 2017, Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis, Rheumatology, 56, 95, 10.1093/rheumatology/kew367 Lambert, 2016, Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group, Ann Rheum Dis, 75, 1958, 10.1136/annrheumdis-2015-208642 Van Onna, 2015, Natural course of bone marrow oedema on magnetic resonance imaging of the sacroiliac joints in patients with early inflammatory back pain: a 2-year follow-up study, Scand J Rheumatol, 44, 129, 10.3109/03009742.2014.933247 Jarratt, 2009, MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib, Ann Rheum Dis, 68, 1466, 10.1136/ard.2008.092213 Dougados, 1999, Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks nonsteroidal anti-inflammatory drug trial, Rheumatol, 38, 235, 10.1093/rheumatology/38.3.235 Agafonova, 2018, AB0830 MRI evaluation of the effect of ankylosing spondylitis treatment on hip joints involvement, Ann Rheum Dis, 77, 1543 Wanders, 2005, Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial, Arthritis Rheum, 52, 1756, 10.1002/art.21054 Poddubnyy, 2015, Brief report: Clinical course over two years in patients with early nonradiographic axial spondyloarthritis and patients with ankylosing spondylitis not treated with tumor necrosis factor blockers: results from the German Spondyloarthritis Inception Cohort, Arthritis Rheumatol, 67, 2369, 10.1002/art.39225